Abstract

Peptidoglycan (PG) is an essential component of the bacterial cell envelope. This macromolecule consists of glycan chains alternating N-acetylglucosamine and N-acetylmuramic acid, cross-linked by short peptides containing nonstandard amino acids. Structural analysis of PG usually involves enzymatic digestion of glycan strands and separation of disaccharide peptides by reversed-phase HPLC followed by collection of individual peaks for MALDI-TOF and/or tandem mass spectrometry. Here, we report a novel strategy using shotgun proteomics techniques for a systematic and unbiased structural analysis of PG using high-resolution mass spectrometry and automated analysis of HCD and ETD fragmentation spectra with the Byonic software. Using the PG of the nosocomial pathogen Clostridium difficile as a proof of concept, we show that this high-throughput approach allows the identification of all PG monomers and dimers previously described, leaving only disambiguation of 3–3 and 4–3 cross-linking as a manual step. Our analysis confirms previous findings that C. difficile peptidoglycans include mainly deacetylated N-acetylglucosamine residues and 3–3 cross-links. The analysis also revealed a number of low abundance muropeptides with peptide sequences not previously reported.Graphical The bacterial cell envelope includes plasma membrane, peptidoglycan, and surface layer. Peptidoglycan is unique to bacteria and the target of the most important antibiotics; here it is analyzed by mass spectrometry.

Highlights

  • Present addressCovance Laboratories Limited, Otley Road, Harrogate, North Yorkshire HG3 1PY, UK identification of all PG monomers and dimers previously described, leaving only disambiguation of 3–3 and 4–3 crosslinking as a manual step

  • The major and essential polymer within the bacterial cell envelope is peptidoglycan (PG), which forms a single bagshaped macromolecule around the cell [1]

  • PG is unique to the bacterial kingdom, and its synthesis is the target of the most clinically important antibiotics ever discovered such as the beta-lactams and glycopeptides

Read more

Summary

Present address

Covance Laboratories Limited, Otley Road, Harrogate, North Yorkshire HG3 1PY, UK identification of all PG monomers and dimers previously described, leaving only disambiguation of 3–3 and 4–3 crosslinking as a manual step. Our analysis confirms previous findings that C. difficile peptidoglycans include mainly deacetylated N-acetylglucosamine residues and 3–3 crosslinks. The analysis revealed a number of low abundance muropeptides with peptide sequences not previously reported.

Introduction
Results and discussion
Conclusion
Compliance with ethical standards
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call